nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SERPINA6—Triamcinolone—hematologic cancer	0.177	0.417	CbGbCtD
Mitotane—SERPINA6—Prednisolone—hematologic cancer	0.15	0.353	CbGbCtD
Mitotane—CYP11A1—Dexamethasone—hematologic cancer	0.0977	0.23	CbGbCtD
Mitotane—FDX1—ovarian follicle—hematologic cancer	0.0598	0.393	CbGeAlD
Mitotane—CYP11A1—ovarian follicle—hematologic cancer	0.0272	0.179	CbGeAlD
Mitotane—CYP11B1—hematopoietic system—hematologic cancer	0.00578	0.038	CbGeAlD
Mitotane—FDX1—gonad—hematologic cancer	0.00549	0.0361	CbGeAlD
Mitotane—FDX1—blood—hematologic cancer	0.00479	0.0315	CbGeAlD
Mitotane—FDX1—bone marrow—hematologic cancer	0.00463	0.0304	CbGeAlD
Mitotane—FDX1—lung—hematologic cancer	0.0042	0.0276	CbGeAlD
Mitotane—FDX1—testis—hematologic cancer	0.00396	0.026	CbGeAlD
Mitotane—CYP11B1—blood—hematologic cancer	0.00383	0.0251	CbGeAlD
Mitotane—CYP11A1—hematopoietic system—hematologic cancer	0.00328	0.0216	CbGeAlD
Mitotane—SERPINA6—hematopoietic system—hematologic cancer	0.00312	0.0205	CbGeAlD
Mitotane—FDX1—lymph node—hematologic cancer	0.00287	0.0189	CbGeAlD
Mitotane—SHBG—hematopoietic system—hematologic cancer	0.00263	0.0173	CbGeAlD
Mitotane—CYP11A1—gonad—hematologic cancer	0.0025	0.0164	CbGeAlD
Mitotane—CYP11A1—blood—hematologic cancer	0.00217	0.0143	CbGeAlD
Mitotane—SERPINA6—blood—hematologic cancer	0.00207	0.0136	CbGeAlD
Mitotane—SERPINA6—bone marrow—hematologic cancer	0.002	0.0132	CbGeAlD
Mitotane—SHBG—gonad—hematologic cancer	0.002	0.0131	CbGeAlD
Mitotane—SERPINA6—lung—hematologic cancer	0.00181	0.0119	CbGeAlD
Mitotane—CYP11A1—testis—hematologic cancer	0.0018	0.0118	CbGeAlD
Mitotane—SHBG—blood—hematologic cancer	0.00174	0.0115	CbGeAlD
Mitotane—SHBG—bone marrow—hematologic cancer	0.00169	0.0111	CbGeAlD
Mitotane—SHBG—testis—hematologic cancer	0.00144	0.00947	CbGeAlD
Mitotane—CYP11A1—lymph node—hematologic cancer	0.0013	0.00857	CbGeAlD
Mitotane—CYP11A1—Biological oxidations—MTR—hematologic cancer	0.000195	0.00346	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTAP—hematologic cancer	0.00019	0.00338	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTT1—hematologic cancer	0.000185	0.00329	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK14—hematologic cancer	0.000182	0.00324	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—NFKBIA—hematologic cancer	0.000175	0.0031	CbGpPWpGaD
Mitotane—FDX1—Metabolism—FHL2—hematologic cancer	0.00017	0.00301	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000167	0.00296	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AGRN—hematologic cancer	0.000166	0.00295	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—FOS—hematologic cancer	0.000161	0.00286	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CREB1—hematologic cancer	0.000161	0.00286	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—BRAF—hematologic cancer	0.000159	0.00282	CbGpPWpGaD
Mitotane—FDX1—Metabolism—IDH2—hematologic cancer	0.000158	0.0028	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HMMR—hematologic cancer	0.000158	0.0028	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK14—hematologic cancer	0.000156	0.00277	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—GSTP1—hematologic cancer	0.00015	0.00267	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAP2K1—hematologic cancer	0.00015	0.00265	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—NFKBIA—hematologic cancer	0.000149	0.00265	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000149	0.00264	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ARNTL—hematologic cancer	0.000148	0.00263	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—GSTP1—hematologic cancer	0.000148	0.00263	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ACP5—hematologic cancer	0.000144	0.00256	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CA9—hematologic cancer	0.000144	0.00256	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000142	0.00253	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NCOR2—hematologic cancer	0.000142	0.00253	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—GSTM1—hematologic cancer	0.000138	0.00245	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—FOS—hematologic cancer	0.000138	0.00245	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CREB1—hematologic cancer	0.000138	0.00244	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—GSTM1—hematologic cancer	0.000136	0.00242	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—BRAF—hematologic cancer	0.000136	0.00241	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000136	0.00241	CbGpPWpGaD
Mitotane—FDX1—Metabolism—IDH1—hematologic cancer	0.000136	0.00241	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—BCL2—hematologic cancer	0.000135	0.0024	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TXN—hematologic cancer	0.000134	0.00238	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCC3—hematologic cancer	0.000134	0.00238	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTO1—hematologic cancer	0.000134	0.00238	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SPHK1—hematologic cancer	0.000131	0.00233	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTP1—hematologic cancer	0.000129	0.00228	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAP2K1—hematologic cancer	0.000128	0.00227	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—GSTP1—hematologic cancer	0.000127	0.00225	CbGpPWpGaD
Mitotane—FDX1—Metabolism—UGT1A1—hematologic cancer	0.000126	0.00224	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SLC22A1—hematologic cancer	0.000123	0.00218	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CRABP1—hematologic cancer	0.000123	0.00218	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALOX5—hematologic cancer	0.00012	0.00212	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CASP3—hematologic cancer	0.000119	0.00211	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IL2—hematologic cancer	0.000119	0.00211	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000119	0.00211	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTM1—hematologic cancer	0.000118	0.0021	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—GSTM1—hematologic cancer	0.000116	0.00207	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000116	0.00206	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NUP98—hematologic cancer	0.000116	0.00205	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—BCL2—hematologic cancer	0.000116	0.00205	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GMPS—hematologic cancer	0.000115	0.00204	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PHYH—hematologic cancer	0.000115	0.00204	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—FTCD—hematologic cancer	0.000115	0.00204	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000114	0.00202	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ADCY7—hematologic cancer	0.000112	0.00199	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NCOA3—hematologic cancer	0.000112	0.00199	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NUP214—hematologic cancer	0.000112	0.00198	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.00011	0.00196	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK8—hematologic cancer	0.00011	0.00194	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTR—hematologic cancer	0.000109	0.00194	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCG2—hematologic cancer	0.000109	0.00194	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000109	0.00193	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000107	0.0019	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ENO2—hematologic cancer	0.000107	0.0019	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SMPD3—hematologic cancer	0.000105	0.00187	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.000105	0.00186	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTT1—hematologic cancer	0.000104	0.00185	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000102	0.00182	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CASP3—hematologic cancer	0.000102	0.00181	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IL2—hematologic cancer	0.000102	0.00181	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SDC1—hematologic cancer	0.000102	0.0018	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000102	0.0018	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GMPS—hematologic cancer	9.85e-05	0.00175	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—FTCD—hematologic cancer	9.85e-05	0.00175	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PHYH—hematologic cancer	9.85e-05	0.00175	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	9.82e-05	0.00174	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	9.75e-05	0.00173	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.71e-05	0.00172	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.59e-05	0.0017	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK3—hematologic cancer	9.57e-05	0.0017	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	9.57e-05	0.0017	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK8—hematologic cancer	9.37e-05	0.00166	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	9.29e-05	0.00165	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TGFB1—hematologic cancer	9.28e-05	0.00165	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—B3GAT1—hematologic cancer	9.2e-05	0.00163	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—DCK—hematologic cancer	9.2e-05	0.00163	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ASNS—hematologic cancer	9.2e-05	0.00163	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	9.18e-05	0.00163	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.17e-05	0.00163	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SMPD3—hematologic cancer	9.01e-05	0.0016	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	8.99e-05	0.0016	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	8.99e-05	0.00159	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HDC—hematologic cancer	8.72e-05	0.00155	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NQO1—hematologic cancer	8.65e-05	0.00153	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CD44—hematologic cancer	8.65e-05	0.00153	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.47e-05	0.0015	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	8.4e-05	0.00149	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK3—hematologic cancer	8.18e-05	0.00145	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	8.18e-05	0.00145	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYCS—hematologic cancer	8.18e-05	0.00145	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	8.13e-05	0.00144	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HSP90AA1—hematologic cancer	8.13e-05	0.00144	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CDA—hematologic cancer	7.98e-05	0.00142	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—hematologic cancer	7.94e-05	0.00141	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—B3GAT1—hematologic cancer	7.87e-05	0.0014	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—DCK—hematologic cancer	7.87e-05	0.0014	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ASNS—hematologic cancer	7.87e-05	0.0014	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	7.69e-05	0.00137	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PC—hematologic cancer	7.68e-05	0.00136	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HDC—hematologic cancer	7.46e-05	0.00132	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC35B2—hematologic cancer	7.42e-05	0.00132	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GBA—hematologic cancer	7.42e-05	0.00132	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.32e-05	0.0013	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTP1—hematologic cancer	7.21e-05	0.00128	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.98e-05	0.00124	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	6.96e-05	0.00123	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CDA—hematologic cancer	6.83e-05	0.00121	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCB1—hematologic cancer	6.83e-05	0.00121	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTAP—hematologic cancer	6.78e-05	0.0012	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTM1—hematologic cancer	6.63e-05	0.00118	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NCOR1—hematologic cancer	6.63e-05	0.00118	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PC—hematologic cancer	6.57e-05	0.00117	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—hematologic cancer	6.45e-05	0.00114	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GBA—hematologic cancer	6.35e-05	0.00113	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC35B2—hematologic cancer	6.35e-05	0.00113	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—FHL2—hematologic cancer	6.05e-05	0.00107	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AGRN—hematologic cancer	5.93e-05	0.00105	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTHFR—hematologic cancer	5.86e-05	0.00104	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTAP—hematologic cancer	5.8e-05	0.00103	CbGpPWpGaD
Mitotane—Feeling abnormal—Prednisolone—hematologic cancer	5.69e-05	0.000155	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—hematologic cancer	5.69e-05	0.000155	CcSEcCtD
Mitotane—Anaemia—Prednisone—hematologic cancer	5.68e-05	0.000155	CcSEcCtD
Mitotane—Headache—Carmustine—hematologic cancer	5.67e-05	0.000155	CcSEcCtD
Mitotane—Shock—Betamethasone—hematologic cancer	5.67e-05	0.000154	CcSEcCtD
Mitotane—Shock—Dexamethasone—hematologic cancer	5.67e-05	0.000154	CcSEcCtD
Mitotane—Rash—Alitretinoin—hematologic cancer	5.65e-05	0.000154	CcSEcCtD
Mitotane—Nervous system disorder—Betamethasone—hematologic cancer	5.65e-05	0.000154	CcSEcCtD
Mitotane—Nervous system disorder—Dexamethasone—hematologic cancer	5.65e-05	0.000154	CcSEcCtD
Mitotane—Dermatitis—Alitretinoin—hematologic cancer	5.65e-05	0.000154	CcSEcCtD
Mitotane—Thrombocytopenia—Betamethasone—hematologic cancer	5.64e-05	0.000154	CcSEcCtD
Mitotane—Thrombocytopenia—Dexamethasone—hematologic cancer	5.64e-05	0.000154	CcSEcCtD
Mitotane—Vomiting—Ifosfamide—hematologic cancer	5.63e-05	0.000154	CcSEcCtD
Mitotane—Hypersensitivity—Cisplatin—hematologic cancer	5.63e-05	0.000153	CcSEcCtD
Mitotane—CYP11B1—Metabolism—IDH2—hematologic cancer	5.62e-05	0.000997	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMMR—hematologic cancer	5.62e-05	0.000997	CbGpPWpGaD
Mitotane—Headache—Alitretinoin—hematologic cancer	5.62e-05	0.000153	CcSEcCtD
Mitotane—Diarrhoea—Gemcitabine—hematologic cancer	5.61e-05	0.000153	CcSEcCtD
Mitotane—Nausea—Thalidomide—hematologic cancer	5.6e-05	0.000153	CcSEcCtD
Mitotane—Dyspepsia—Triamcinolone—hematologic cancer	5.59e-05	0.000152	CcSEcCtD
Mitotane—Rash—Ifosfamide—hematologic cancer	5.59e-05	0.000152	CcSEcCtD
Mitotane—Dermatitis—Ifosfamide—hematologic cancer	5.58e-05	0.000152	CcSEcCtD
Mitotane—Dizziness—Irinotecan—hematologic cancer	5.56e-05	0.000152	CcSEcCtD
Mitotane—Body temperature increased—Etoposide—hematologic cancer	5.53e-05	0.000151	CcSEcCtD
Mitotane—Vertigo—Prednisone—hematologic cancer	5.52e-05	0.000151	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—hematologic cancer	5.52e-05	0.000151	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—hematologic cancer	5.52e-05	0.000979	CbGpPWpGaD
Mitotane—Eye disorder—Methotrexate—hematologic cancer	5.52e-05	0.00015	CcSEcCtD
Mitotane—Vomiting—Vincristine—hematologic cancer	5.49e-05	0.00015	CcSEcCtD
Mitotane—Anorexia—Dexamethasone—hematologic cancer	5.49e-05	0.00015	CcSEcCtD
Mitotane—Anorexia—Betamethasone—hematologic cancer	5.49e-05	0.00015	CcSEcCtD
Mitotane—Asthenia—Cisplatin—hematologic cancer	5.48e-05	0.000149	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—hematologic cancer	5.45e-05	0.000149	CcSEcCtD
Mitotane—Rash—Vincristine—hematologic cancer	5.45e-05	0.000148	CcSEcCtD
Mitotane—Dermatitis—Vincristine—hematologic cancer	5.44e-05	0.000148	CcSEcCtD
Mitotane—Pain—Triamcinolone—hematologic cancer	5.43e-05	0.000148	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—hematologic cancer	5.43e-05	0.000148	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—hematologic cancer	5.43e-05	0.000148	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—hematologic cancer	5.41e-05	0.000148	CcSEcCtD
Mitotane—Headache—Vincristine—hematologic cancer	5.41e-05	0.000148	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.38e-05	0.000147	CcSEcCtD
Mitotane—Hypotension—Betamethasone—hematologic cancer	5.38e-05	0.000147	CcSEcCtD
Mitotane—Hypotension—Dexamethasone—hematologic cancer	5.38e-05	0.000147	CcSEcCtD
Mitotane—Nausea—Carmustine—hematologic cancer	5.38e-05	0.000147	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—hematologic cancer	5.35e-05	0.000146	CcSEcCtD
Mitotane—Vomiting—Irinotecan—hematologic cancer	5.35e-05	0.000146	CcSEcCtD
Mitotane—Vomiting—Mitoxantrone—hematologic cancer	5.35e-05	0.000146	CcSEcCtD
Mitotane—Nausea—Alitretinoin—hematologic cancer	5.33e-05	0.000145	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—hematologic cancer	5.32e-05	0.000145	CcSEcCtD
Mitotane—Hypertension—Prednisone—hematologic cancer	5.31e-05	0.000145	CcSEcCtD
Mitotane—Rash—Mitoxantrone—hematologic cancer	5.31e-05	0.000145	CcSEcCtD
Mitotane—Rash—Irinotecan—hematologic cancer	5.31e-05	0.000145	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.3e-05	0.000941	CbGpPWpGaD
Mitotane—Dermatitis—Mitoxantrone—hematologic cancer	5.3e-05	0.000144	CcSEcCtD
Mitotane—Dermatitis—Irinotecan—hematologic cancer	5.3e-05	0.000144	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ARNTL—hematologic cancer	5.29e-05	0.000938	CbGpPWpGaD
Mitotane—Headache—Mitoxantrone—hematologic cancer	5.27e-05	0.000144	CcSEcCtD
Mitotane—Headache—Irinotecan—hematologic cancer	5.27e-05	0.000144	CcSEcCtD
Mitotane—Nausea—Ifosfamide—hematologic cancer	5.26e-05	0.000143	CcSEcCtD
Mitotane—Feeling abnormal—Triamcinolone—hematologic cancer	5.23e-05	0.000143	CcSEcCtD
Mitotane—Diarrhoea—Cisplatin—hematologic cancer	5.23e-05	0.000142	CcSEcCtD
Mitotane—Vomiting—Gemcitabine—hematologic cancer	5.21e-05	0.000142	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.2e-05	0.000142	CcSEcCtD
Mitotane—CYP11A1—Metabolism—FHL2—hematologic cancer	5.17e-05	0.000918	CbGpPWpGaD
Mitotane—Paraesthesia—Dexamethasone—hematologic cancer	5.17e-05	0.000141	CcSEcCtD
Mitotane—Paraesthesia—Betamethasone—hematologic cancer	5.17e-05	0.000141	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—hematologic cancer	5.17e-05	0.000141	CcSEcCtD
Mitotane—Rash—Gemcitabine—hematologic cancer	5.17e-05	0.000141	CcSEcCtD
Mitotane—Dermatitis—Gemcitabine—hematologic cancer	5.16e-05	0.000141	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.16e-05	0.000916	CbGpPWpGaD
Mitotane—Eye disorder—Epirubicin—hematologic cancer	5.16e-05	0.000141	CcSEcCtD
Mitotane—Hypersensitivity—Etoposide—hematologic cancer	5.16e-05	0.000141	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CA9—hematologic cancer	5.14e-05	0.000912	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ACP5—hematologic cancer	5.14e-05	0.000912	CbGpPWpGaD
Mitotane—Malnutrition—Methotrexate—hematologic cancer	5.14e-05	0.00014	CcSEcCtD
Mitotane—Headache—Gemcitabine—hematologic cancer	5.14e-05	0.00014	CcSEcCtD
Mitotane—Nausea—Vincristine—hematologic cancer	5.13e-05	0.00014	CcSEcCtD
Mitotane—Flushing—Epirubicin—hematologic cancer	5.13e-05	0.00014	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—hematologic cancer	5.11e-05	0.000139	CcSEcCtD
Mitotane—Hypersensitivity—Prednisolone—hematologic cancer	5.09e-05	0.000139	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NCOR2—hematologic cancer	5.07e-05	0.0009	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AGRN—hematologic cancer	5.07e-05	0.0009	CbGpPWpGaD
Mitotane—Dyspepsia—Dexamethasone—hematologic cancer	5.07e-05	0.000138	CcSEcCtD
Mitotane—Dyspepsia—Betamethasone—hematologic cancer	5.07e-05	0.000138	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—hematologic cancer	5.05e-05	0.000138	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—hematologic cancer	5.03e-05	0.000137	CcSEcCtD
Mitotane—Asthenia—Etoposide—hematologic cancer	5.02e-05	0.000137	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—hematologic cancer	5.02e-05	0.000137	CcSEcCtD
Mitotane—Body temperature increased—Triamcinolone—hematologic cancer	5.02e-05	0.000137	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—hematologic cancer	5.01e-05	0.000137	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—hematologic cancer	5.01e-05	0.000137	CcSEcCtD
Mitotane—Decreased appetite—Dexamethasone—hematologic cancer	5.01e-05	0.000136	CcSEcCtD
Mitotane—Decreased appetite—Betamethasone—hematologic cancer	5.01e-05	0.000136	CcSEcCtD
Mitotane—Nausea—Mitoxantrone—hematologic cancer	5e-05	0.000136	CcSEcCtD
Mitotane—Nausea—Irinotecan—hematologic cancer	5e-05	0.000136	CcSEcCtD
Mitotane—Infection—Prednisone—hematologic cancer	4.98e-05	0.000136	CcSEcCtD
Mitotane—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.97e-05	0.000136	CcSEcCtD
Mitotane—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.97e-05	0.000136	CcSEcCtD
Mitotane—Shock—Prednisone—hematologic cancer	4.94e-05	0.000135	CcSEcCtD
Mitotane—Pain—Betamethasone—hematologic cancer	4.93e-05	0.000134	CcSEcCtD
Mitotane—Pain—Dexamethasone—hematologic cancer	4.93e-05	0.000134	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—hematologic cancer	4.92e-05	0.000134	CcSEcCtD
Mitotane—FDX1—Metabolism—PIK3CG—hematologic cancer	4.92e-05	0.000873	CbGpPWpGaD
Mitotane—Nervous system disorder—Prednisone—hematologic cancer	4.92e-05	0.000134	CcSEcCtD
Mitotane—Skin disorder—Prednisone—hematologic cancer	4.87e-05	0.000133	CcSEcCtD
Mitotane—Nausea—Gemcitabine—hematologic cancer	4.87e-05	0.000133	CcSEcCtD
Mitotane—Vomiting—Cisplatin—hematologic cancer	4.86e-05	0.000132	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—hematologic cancer	4.84e-05	0.000132	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—hematologic cancer	4.84e-05	0.000132	CcSEcCtD
Mitotane—CYP11B1—Metabolism—IDH1—hematologic cancer	4.83e-05	0.000858	CbGpPWpGaD
Mitotane—Rash—Cisplatin—hematologic cancer	4.82e-05	0.000131	CcSEcCtD
Mitotane—Dermatitis—Cisplatin—hematologic cancer	4.81e-05	0.000131	CcSEcCtD
Mitotane—CYP11A1—Metabolism—IDH2—hematologic cancer	4.81e-05	0.000853	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMMR—hematologic cancer	4.81e-05	0.000853	CbGpPWpGaD
Mitotane—Malnutrition—Epirubicin—hematologic cancer	4.81e-05	0.000131	CcSEcCtD
Mitotane—Diarrhoea—Etoposide—hematologic cancer	4.79e-05	0.000131	CcSEcCtD
Mitotane—Anorexia—Prednisone—hematologic cancer	4.78e-05	0.00013	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ABCC3—hematologic cancer	4.78e-05	0.000848	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTO1—hematologic cancer	4.78e-05	0.000848	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TXN—hematologic cancer	4.78e-05	0.000848	CbGpPWpGaD
Mitotane—Eye disorder—Doxorubicin—hematologic cancer	4.78e-05	0.00013	CcSEcCtD
Mitotane—Anaemia—Methotrexate—hematologic cancer	4.75e-05	0.000129	CcSEcCtD
Mitotane—Feeling abnormal—Betamethasone—hematologic cancer	4.75e-05	0.000129	CcSEcCtD
Mitotane—Feeling abnormal—Dexamethasone—hematologic cancer	4.75e-05	0.000129	CcSEcCtD
Mitotane—Flushing—Doxorubicin—hematologic cancer	4.74e-05	0.000129	CcSEcCtD
Mitotane—Dysgeusia—Epirubicin—hematologic cancer	4.71e-05	0.000128	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SPHK1—hematologic cancer	4.68e-05	0.00083	CbGpPWpGaD
Mitotane—Hypersensitivity—Triamcinolone—hematologic cancer	4.68e-05	0.000127	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—hematologic cancer	4.64e-05	0.000126	CcSEcCtD
Mitotane—Dizziness—Etoposide—hematologic cancer	4.63e-05	0.000126	CcSEcCtD
Mitotane—Vertigo—Methotrexate—hematologic cancer	4.62e-05	0.000126	CcSEcCtD
Mitotane—Dizziness—Prednisolone—hematologic cancer	4.57e-05	0.000124	CcSEcCtD
Mitotane—FDX1—Metabolism—CREBBP—hematologic cancer	4.56e-05	0.000809	CbGpPWpGaD
Mitotane—Asthenia—Triamcinolone—hematologic cancer	4.56e-05	0.000124	CcSEcCtD
Mitotane—Body temperature increased—Dexamethasone—hematologic cancer	4.55e-05	0.000124	CcSEcCtD
Mitotane—Body temperature increased—Betamethasone—hematologic cancer	4.55e-05	0.000124	CcSEcCtD
Mitotane—Nausea—Cisplatin—hematologic cancer	4.54e-05	0.000124	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.54e-05	0.000805	CbGpPWpGaD
Mitotane—Vision blurred—Epirubicin—hematologic cancer	4.53e-05	0.000123	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ARNTL—hematologic cancer	4.52e-05	0.000802	CbGpPWpGaD
Mitotane—Paraesthesia—Prednisone—hematologic cancer	4.5e-05	0.000123	CcSEcCtD
Mitotane—CYP11B1—Metabolism—UGT1A1—hematologic cancer	4.49e-05	0.000797	CbGpPWpGaD
Mitotane—Mental disorder—Doxorubicin—hematologic cancer	4.48e-05	0.000122	CcSEcCtD
Mitotane—Vomiting—Etoposide—hematologic cancer	4.45e-05	0.000121	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—hematologic cancer	4.45e-05	0.000121	CcSEcCtD
Mitotane—Anaemia—Epirubicin—hematologic cancer	4.44e-05	0.000121	CcSEcCtD
Mitotane—Dyspepsia—Prednisone—hematologic cancer	4.42e-05	0.00012	CcSEcCtD
Mitotane—Rash—Etoposide—hematologic cancer	4.41e-05	0.00012	CcSEcCtD
Mitotane—Dermatitis—Etoposide—hematologic cancer	4.41e-05	0.00012	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ACP5—hematologic cancer	4.4e-05	0.00078	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA9—hematologic cancer	4.4e-05	0.00078	CbGpPWpGaD
Mitotane—Headache—Etoposide—hematologic cancer	4.39e-05	0.00012	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SLC22A1—hematologic cancer	4.37e-05	0.000776	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CRABP1—hematologic cancer	4.37e-05	0.000776	CbGpPWpGaD
Mitotane—Decreased appetite—Prednisone—hematologic cancer	4.36e-05	0.000119	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—hematologic cancer	4.36e-05	0.000119	CcSEcCtD
Mitotane—Rash—Prednisolone—hematologic cancer	4.35e-05	0.000119	CcSEcCtD
Mitotane—Dermatitis—Prednisolone—hematologic cancer	4.35e-05	0.000119	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.34e-05	0.000118	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NCOR2—hematologic cancer	4.34e-05	0.00077	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CD—hematologic cancer	4.33e-05	0.000767	CbGpPWpGaD
Mitotane—Headache—Prednisolone—hematologic cancer	4.33e-05	0.000118	CcSEcCtD
Mitotane—Vertigo—Epirubicin—hematologic cancer	4.32e-05	0.000118	CcSEcCtD
Mitotane—FDX1—Metabolism—ALB—hematologic cancer	4.27e-05	0.000758	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALOX5—hematologic cancer	4.26e-05	0.000756	CbGpPWpGaD
Mitotane—Confusional state—Methotrexate—hematologic cancer	4.23e-05	0.000115	CcSEcCtD
Mitotane—Dizziness—Triamcinolone—hematologic cancer	4.2e-05	0.000114	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—hematologic cancer	4.19e-05	0.000114	CcSEcCtD
Mitotane—Infection—Methotrexate—hematologic cancer	4.17e-05	0.000114	CcSEcCtD
Mitotane—Nausea—Etoposide—hematologic cancer	4.16e-05	0.000113	CcSEcCtD
Mitotane—Hypertension—Epirubicin—hematologic cancer	4.15e-05	0.000113	CcSEcCtD
Mitotane—CYP11A1—Metabolism—IDH1—hematologic cancer	4.14e-05	0.000734	CbGpPWpGaD
Mitotane—Feeling abnormal—Prednisone—hematologic cancer	4.13e-05	0.000113	CcSEcCtD
Mitotane—Asthenia—Dexamethasone—hematologic cancer	4.13e-05	0.000113	CcSEcCtD
Mitotane—Asthenia—Betamethasone—hematologic cancer	4.13e-05	0.000113	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NUP98—hematologic cancer	4.13e-05	0.000732	CbGpPWpGaD
Mitotane—Nervous system disorder—Methotrexate—hematologic cancer	4.11e-05	0.000112	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—hematologic cancer	4.11e-05	0.000112	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—hematologic cancer	4.11e-05	0.000112	CcSEcCtD
Mitotane—Nausea—Prednisolone—hematologic cancer	4.1e-05	0.000112	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ABCC3—hematologic cancer	4.09e-05	0.000726	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTO1—hematologic cancer	4.09e-05	0.000726	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TXN—hematologic cancer	4.09e-05	0.000726	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3R1—hematologic cancer	4.08e-05	0.000725	CbGpPWpGaD
Mitotane—Skin disorder—Methotrexate—hematologic cancer	4.07e-05	0.000111	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.06e-05	0.000111	CcSEcCtD
Mitotane—Vomiting—Triamcinolone—hematologic cancer	4.04e-05	0.00011	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ADCY7—hematologic cancer	4.01e-05	0.000711	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOA3—hematologic cancer	4.01e-05	0.000711	CbGpPWpGaD
Mitotane—Rash—Triamcinolone—hematologic cancer	4e-05	0.000109	CcSEcCtD
Mitotane—CYP11A1—Metabolism—SPHK1—hematologic cancer	4e-05	0.00071	CbGpPWpGaD
Mitotane—Dermatitis—Triamcinolone—hematologic cancer	4e-05	0.000109	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—hematologic cancer	4e-05	0.000109	CcSEcCtD
Mitotane—Anorexia—Methotrexate—hematologic cancer	4e-05	0.000109	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NUP214—hematologic cancer	3.98e-05	0.000706	CbGpPWpGaD
Mitotane—Headache—Triamcinolone—hematologic cancer	3.98e-05	0.000108	CcSEcCtD
Mitotane—Body temperature increased—Prednisone—hematologic cancer	3.97e-05	0.000108	CcSEcCtD
Mitotane—Confusional state—Epirubicin—hematologic cancer	3.96e-05	0.000108	CcSEcCtD
Mitotane—Diarrhoea—Betamethasone—hematologic cancer	3.94e-05	0.000107	CcSEcCtD
Mitotane—Diarrhoea—Dexamethasone—hematologic cancer	3.94e-05	0.000107	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.94e-05	0.000698	CbGpPWpGaD
Mitotane—Hypotension—Methotrexate—hematologic cancer	3.92e-05	0.000107	CcSEcCtD
Mitotane—Infection—Epirubicin—hematologic cancer	3.9e-05	0.000106	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ABCG2—hematologic cancer	3.9e-05	0.000691	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTR—hematologic cancer	3.9e-05	0.000691	CbGpPWpGaD
Mitotane—Shock—Epirubicin—hematologic cancer	3.86e-05	0.000105	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—hematologic cancer	3.85e-05	0.000105	CcSEcCtD
Mitotane—CYP11A1—Metabolism—UGT1A1—hematologic cancer	3.84e-05	0.000682	CbGpPWpGaD
Mitotane—Thrombocytopenia—Epirubicin—hematologic cancer	3.84e-05	0.000105	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—hematologic cancer	3.84e-05	0.000105	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ENO2—hematologic cancer	3.82e-05	0.000678	CbGpPWpGaD
Mitotane—Skin disorder—Epirubicin—hematologic cancer	3.81e-05	0.000104	CcSEcCtD
Mitotane—Dizziness—Dexamethasone—hematologic cancer	3.81e-05	0.000104	CcSEcCtD
Mitotane—Dizziness—Betamethasone—hematologic cancer	3.81e-05	0.000104	CcSEcCtD
Mitotane—Nausea—Triamcinolone—hematologic cancer	3.77e-05	0.000103	CcSEcCtD
Mitotane—FDX1—Metabolism—PIK3CB—hematologic cancer	3.77e-05	0.000669	CbGpPWpGaD
Mitotane—Paraesthesia—Methotrexate—hematologic cancer	3.76e-05	0.000103	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.76e-05	0.000103	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CRABP1—hematologic cancer	3.74e-05	0.000664	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC22A1—hematologic cancer	3.74e-05	0.000664	CbGpPWpGaD
Mitotane—Anorexia—Epirubicin—hematologic cancer	3.74e-05	0.000102	CcSEcCtD
Mitotane—Somnolence—Methotrexate—hematologic cancer	3.73e-05	0.000102	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GSTT1—hematologic cancer	3.71e-05	0.000658	CbGpPWpGaD
Mitotane—Hypersensitivity—Prednisone—hematologic cancer	3.7e-05	0.000101	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—hematologic cancer	3.69e-05	0.000101	CcSEcCtD
Mitotane—Hypotension—Epirubicin—hematologic cancer	3.67e-05	9.99e-05	CcSEcCtD
Mitotane—Vomiting—Betamethasone—hematologic cancer	3.66e-05	9.98e-05	CcSEcCtD
Mitotane—Vomiting—Dexamethasone—hematologic cancer	3.66e-05	9.98e-05	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—hematologic cancer	3.66e-05	9.98e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.65e-05	0.000648	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALOX5—hematologic cancer	3.64e-05	0.000647	CbGpPWpGaD
Mitotane—Decreased appetite—Methotrexate—hematologic cancer	3.64e-05	9.93e-05	CcSEcCtD
Mitotane—Rash—Betamethasone—hematologic cancer	3.63e-05	9.9e-05	CcSEcCtD
Mitotane—Rash—Dexamethasone—hematologic cancer	3.63e-05	9.9e-05	CcSEcCtD
Mitotane—Dermatitis—Dexamethasone—hematologic cancer	3.63e-05	9.89e-05	CcSEcCtD
Mitotane—Dermatitis—Betamethasone—hematologic cancer	3.63e-05	9.89e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SDC1—hematologic cancer	3.62e-05	0.000643	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.62e-05	9.87e-05	CcSEcCtD
Mitotane—Headache—Dexamethasone—hematologic cancer	3.61e-05	9.84e-05	CcSEcCtD
Mitotane—Headache—Betamethasone—hematologic cancer	3.61e-05	9.84e-05	CcSEcCtD
Mitotane—Infection—Doxorubicin—hematologic cancer	3.61e-05	9.83e-05	CcSEcCtD
Mitotane—Asthenia—Prednisone—hematologic cancer	3.6e-05	9.81e-05	CcSEcCtD
Mitotane—Pain—Methotrexate—hematologic cancer	3.59e-05	9.77e-05	CcSEcCtD
Mitotane—Shock—Doxorubicin—hematologic cancer	3.57e-05	9.73e-05	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—hematologic cancer	3.56e-05	9.7e-05	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—hematologic cancer	3.55e-05	9.69e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NUP98—hematologic cancer	3.53e-05	0.000626	CbGpPWpGaD
Mitotane—Skin disorder—Doxorubicin—hematologic cancer	3.53e-05	9.61e-05	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—hematologic cancer	3.52e-05	9.6e-05	CcSEcCtD
Mitotane—Somnolence—Epirubicin—hematologic cancer	3.49e-05	9.51e-05	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—hematologic cancer	3.46e-05	9.43e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.46e-05	0.000614	CbGpPWpGaD
Mitotane—Feeling abnormal—Methotrexate—hematologic cancer	3.46e-05	9.42e-05	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—hematologic cancer	3.45e-05	9.41e-05	CcSEcCtD
Mitotane—Diarrhoea—Prednisone—hematologic cancer	3.43e-05	9.35e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ADCY7—hematologic cancer	3.43e-05	0.000608	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOA3—hematologic cancer	3.43e-05	0.000608	CbGpPWpGaD
Mitotane—Nausea—Betamethasone—hematologic cancer	3.42e-05	9.33e-05	CcSEcCtD
Mitotane—Nausea—Dexamethasone—hematologic cancer	3.42e-05	9.33e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.42e-05	0.000606	CbGpPWpGaD
Mitotane—Decreased appetite—Epirubicin—hematologic cancer	3.41e-05	9.3e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NUP214—hematologic cancer	3.4e-05	0.000604	CbGpPWpGaD
Mitotane—Hypotension—Doxorubicin—hematologic cancer	3.39e-05	9.25e-05	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.39e-05	9.23e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.37e-05	0.000597	CbGpPWpGaD
Mitotane—Pain—Epirubicin—hematologic cancer	3.36e-05	9.14e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ABCG2—hematologic cancer	3.33e-05	0.000591	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTR—hematologic cancer	3.33e-05	0.000591	CbGpPWpGaD
Mitotane—Dizziness—Prednisone—hematologic cancer	3.32e-05	9.04e-05	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—hematologic cancer	3.31e-05	9.03e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ENO2—hematologic cancer	3.27e-05	0.00058	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.27e-05	0.00058	CbGpPWpGaD
Mitotane—Paraesthesia—Doxorubicin—hematologic cancer	3.26e-05	8.88e-05	CcSEcCtD
Mitotane—FDX1—Metabolism—PTEN—hematologic cancer	3.26e-05	0.000578	CbGpPWpGaD
Mitotane—Feeling abnormal—Epirubicin—hematologic cancer	3.23e-05	8.81e-05	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—hematologic cancer	3.23e-05	8.8e-05	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—hematologic cancer	3.2e-05	8.71e-05	CcSEcCtD
Mitotane—Vomiting—Prednisone—hematologic cancer	3.19e-05	8.69e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—GSTT1—hematologic cancer	3.17e-05	0.000563	CbGpPWpGaD
Mitotane—Rash—Prednisone—hematologic cancer	3.16e-05	8.62e-05	CcSEcCtD
Mitotane—Dermatitis—Prednisone—hematologic cancer	3.16e-05	8.61e-05	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—hematologic cancer	3.16e-05	8.6e-05	CcSEcCtD
Mitotane—Headache—Prednisone—hematologic cancer	3.14e-05	8.57e-05	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.13e-05	8.54e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.12e-05	0.000554	CbGpPWpGaD
Mitotane—FDX1—Metabolism—EP300—hematologic cancer	3.11e-05	0.000551	CbGpPWpGaD
Mitotane—Pain—Doxorubicin—hematologic cancer	3.1e-05	8.46e-05	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—hematologic cancer	3.1e-05	8.45e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—SDC1—hematologic cancer	3.1e-05	0.00055	CbGpPWpGaD
Mitotane—Hypersensitivity—Methotrexate—hematologic cancer	3.09e-05	8.42e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NQO1—hematologic cancer	3.08e-05	0.000546	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CD44—hematologic cancer	3.08e-05	0.000546	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.02e-05	0.000535	CbGpPWpGaD
Mitotane—Asthenia—Methotrexate—hematologic cancer	3.01e-05	8.2e-05	CcSEcCtD
Mitotane—Feeling abnormal—Doxorubicin—hematologic cancer	2.99e-05	8.15e-05	CcSEcCtD
Mitotane—Nausea—Prednisone—hematologic cancer	2.98e-05	8.12e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.96e-05	0.000525	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.92e-05	0.000518	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYCS—hematologic cancer	2.91e-05	0.000517	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSP90AA1—hematologic cancer	2.9e-05	0.000514	CbGpPWpGaD
Mitotane—Hypersensitivity—Epirubicin—hematologic cancer	2.89e-05	7.88e-05	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—hematologic cancer	2.87e-05	7.82e-05	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—hematologic cancer	2.87e-05	7.82e-05	CcSEcCtD
Mitotane—Asthenia—Epirubicin—hematologic cancer	2.82e-05	7.67e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.8e-05	0.000496	CbGpPWpGaD
Mitotane—Dizziness—Methotrexate—hematologic cancer	2.77e-05	7.56e-05	CcSEcCtD
Mitotane—Diarrhoea—Epirubicin—hematologic cancer	2.68e-05	7.32e-05	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—hematologic cancer	2.67e-05	7.29e-05	CcSEcCtD
Mitotane—Vomiting—Methotrexate—hematologic cancer	2.67e-05	7.27e-05	CcSEcCtD
Mitotane—Rash—Methotrexate—hematologic cancer	2.64e-05	7.2e-05	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—hematologic cancer	2.64e-05	7.2e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NQO1—hematologic cancer	2.64e-05	0.000468	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CD44—hematologic cancer	2.64e-05	0.000468	CbGpPWpGaD
Mitotane—Headache—Methotrexate—hematologic cancer	2.63e-05	7.16e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.61e-05	0.000462	CbGpPWpGaD
Mitotane—Asthenia—Doxorubicin—hematologic cancer	2.6e-05	7.1e-05	CcSEcCtD
Mitotane—Dizziness—Epirubicin—hematologic cancer	2.59e-05	7.07e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.58e-05	0.000458	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTP1—hematologic cancer	2.57e-05	0.000456	CbGpPWpGaD
Mitotane—Vomiting—Epirubicin—hematologic cancer	2.49e-05	6.8e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CYCS—hematologic cancer	2.49e-05	0.000442	CbGpPWpGaD
Mitotane—Nausea—Methotrexate—hematologic cancer	2.49e-05	6.79e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.49e-05	0.000441	CbGpPWpGaD
Mitotane—Diarrhoea—Doxorubicin—hematologic cancer	2.48e-05	6.77e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism—HSP90AA1—hematologic cancer	2.48e-05	0.00044	CbGpPWpGaD
Mitotane—Rash—Epirubicin—hematologic cancer	2.47e-05	6.74e-05	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—hematologic cancer	2.47e-05	6.74e-05	CcSEcCtD
Mitotane—Headache—Epirubicin—hematologic cancer	2.46e-05	6.7e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ABCB1—hematologic cancer	2.43e-05	0.000431	CbGpPWpGaD
Mitotane—Dizziness—Doxorubicin—hematologic cancer	2.4e-05	6.54e-05	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NCOR1—hematologic cancer	2.36e-05	0.000419	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTM1—hematologic cancer	2.36e-05	0.000419	CbGpPWpGaD
Mitotane—Nausea—Epirubicin—hematologic cancer	2.33e-05	6.35e-05	CcSEcCtD
Mitotane—Vomiting—Doxorubicin—hematologic cancer	2.31e-05	6.29e-05	CcSEcCtD
Mitotane—FDX1—Metabolism—PIK3CA—hematologic cancer	2.3e-05	0.000408	CbGpPWpGaD
Mitotane—Rash—Doxorubicin—hematologic cancer	2.29e-05	6.24e-05	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—hematologic cancer	2.29e-05	6.23e-05	CcSEcCtD
Mitotane—Headache—Doxorubicin—hematologic cancer	2.27e-05	6.2e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.23e-05	0.000396	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTP1—hematologic cancer	2.2e-05	0.00039	CbGpPWpGaD
Mitotane—Nausea—Doxorubicin—hematologic cancer	2.16e-05	5.88e-05	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.13e-05	0.000377	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—hematologic cancer	2.09e-05	0.00037	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCB1—hematologic cancer	2.08e-05	0.000369	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM1—hematologic cancer	2.02e-05	0.000358	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOR1—hematologic cancer	2.02e-05	0.000358	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—hematologic cancer	1.88e-05	0.000333	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.84e-05	0.000326	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—hematologic cancer	1.78e-05	0.000317	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CG—hematologic cancer	1.75e-05	0.000311	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CREBBP—hematologic cancer	1.63e-05	0.000288	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.57e-05	0.000279	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CD—hematologic cancer	1.54e-05	0.000273	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALB—hematologic cancer	1.52e-05	0.00027	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CG—hematologic cancer	1.5e-05	0.000266	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3R1—hematologic cancer	1.46e-05	0.000258	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CREBBP—hematologic cancer	1.39e-05	0.000247	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CB—hematologic cancer	1.34e-05	0.000238	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CD—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALB—hematologic cancer	1.3e-05	0.000231	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3R1—hematologic cancer	1.24e-05	0.000221	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTEN—hematologic cancer	1.16e-05	0.000206	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CB—hematologic cancer	1.15e-05	0.000204	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—EP300—hematologic cancer	1.11e-05	0.000196	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTEN—hematologic cancer	9.93e-06	0.000176	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—EP300—hematologic cancer	9.47e-06	0.000168	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CA—hematologic cancer	8.19e-06	0.000145	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CA—hematologic cancer	7.01e-06	0.000124	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—hematologic cancer	6.69e-06	0.000119	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—hematologic cancer	5.72e-06	0.000102	CbGpPWpGaD
